Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - magnesium chloride hexahydrate, quantity: 0.1017 g/l; sodium, quantity: 134 mmol/l; sodium lactate, quantity: 3.925 g/l; glucose monohydrate, quantity: 25 g/l; calcium, quantity: 1.25 mmol/l; sodium chloride, quantity: 5.786 g/l; calcium chloride dihydrate, quantity: 0.1838 g/l; chloride, quantity: 102.5 mmol/l; magnesium, quantity: 0.5 mmol/l; lactate, quantity: 35 mmol/l - solution, irrigation - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - chloride, quantity: 102.5 mmol/l; lactate, quantity: 35 mmol/l; sodium chloride, quantity: 5.786 g/l; calcium, quantity: 1.25 mmol/l; sodium, quantity: 134 mmol/l; sodium lactate, quantity: 3.925 g/l; calcium chloride dihydrate, quantity: 0.1838 g/l; magnesium, quantity: 0.5 mmol/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; glucose monohydrate, quantity: 46.75 g/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - glucose monohydrate, quantity: 16.5 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; calcium chloride dihydrate, quantity: 0.1838 g/l; lactate, quantity: 35 mmol/l; calcium, quantity: 1.25 mmol/l; chloride, quantity: 102.5 mmol/l; magnesium, quantity: 0.5 mmol/l; sodium lactate, quantity: 3.925 g/l; sodium, quantity: 134 mmol/l; sodium chloride, quantity: 5.786 g/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 1 mg/ml; cetrimide, quantity: 10 mg/ml - solution, irrigation - excipient ingredients: water for injections; tartrazine; glacial acetic acid - chlorhexidine acetate (0.1 %) with cetrimide (1 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.5 mg/ml; cetrimide, quantity: 5 mg/ml - solution, irrigation - excipient ingredients: glacial acetic acid; water for injections; tartrazine - chlorhexidine acetate (0.05 %) with cetrimide (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - magnesium chloride hexahydrate, quantity: 0.1017 g/l; sodium bicarbonate, quantity: 2.94 g/l; sodium chloride, quantity: 6.136 g/l; glucose monohydrate, quantity: 1.1 g/l (equivalent: glucose, qty 1 g/l); calcium chloride dihydrate, quantity: 0.2205 g/l - solution, dialysis - excipient ingredients: carbon dioxide; water for injections; hydrochloric acid; monobasic sodium phosphate dihydrate - replacement fluid, which is administered intravenously in patients with acute renal failure in intensive care units.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - glucose monohydrate, quantity: 1.1 g/l (equivalent: glucose, qty 1 g/l); sodium bicarbonate, quantity: 2.94 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; calcium chloride dihydrate, quantity: 0.2205 g/l; sodium chloride, quantity: 6.136 g/l; potassium chloride, quantity: 0.2982 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; carbon dioxide; monobasic sodium phosphate dihydrate - replacement fluid, which is administered intravenously in patients with acute renal failure in intensive care units.

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: fresenius medical care philippines, inc.; distributor: fresenius medical care philippines, inc. - peritoneal dialysis solution with 2.3% dextrose - solution for peritoneal dialysis - formulation: each l of solution contains: 22.73 g glucose (dextrose) equivalent to 25.0 g glucose monohydrate 5.786 g sodium chloride 3.925 g sodium lactate 257.3 mg calcium chloride dihydrate 101.7 mg magnesium chloride hexahydrate

Australia - English - Department of Health (Therapeutic Goods Administration)

moogoo skin care pty ltd - 58418 - skin detoxifier - a non-sterile, locally-administered powder compound intended to absorb and remove potentially detrimental (harmful) substances from the skin surface including atypical sebaceous exudates and the allergenic and inflammatory substances associated with demodex mite infestation and rosacea. the absorbent may also act as a physical, desiccant acaricide. after application, the device cannot be reused.

Australia - English - Department of Health (Therapeutic Goods Administration)

moogoo skin care pty ltd - 46206 - skin moisturizing/barrier dressing - the indented purpose of the device is dermal application to essentially healthy, unbroken skin for prophylaxis of radiation dermatitis. the cream is applied following radiation therapy to alleviate dry, irritated and flaky skin.